IP Library Granted Patent US 10,143,774
Granted Patent B2
US 10,143,774 · App. 15/657,868 · Granted Dec 4, 2018

Porous polysaccharide scaffold comprising nano-hydroxyapatite and use for bone formation

Inventors: Joelle Amedee (Bordeaux, FR); Didier Letourneur (Paris, FR); Catherine Le Visage (Paris, FR); Sidi Mohammed Derkaoui (Paris, FR); Jean-Christophe Fricain (Bordeaux, FR); Sylvain Catros (Bordeaux, FR)
Assignees: INSERM (INSTITUT NATIONAL DE LA SANTÉ ET DE LA RECHERCHE MÉDICALE); UNIVERSITE DE BORDEAUX II VICTOR SEGALEN; UNIVERSITÉ PARIS DIDEROT—PARIS 7
A61L27/12A61L27/20A61L27/46A61L27/56C08B37/0018C08B37/0021C08J9/0061C08J9/26C08J9/28A61L2300/112A61L2400/08A61L2400/12A61L2430/02C08J2201/026C08J2201/0444C08J2201/0484C08J2205/022C08J2207/10C08J2305/00C08J2405/02
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,143,774
App. No.
15/657,868
Granted
Dec 4, 2018
Kind
B2
Abstract

The present invention relate to three dimensional porous polysaccharide matrices able to induce mineralization of a tissue in osseous site, as well as in non-osseous site, in the absence of stem cells or growth factors.

Claims (23)

1. A porous polysaccharide scaffold obtained by:

i) preparing an alkaline aqueous solution comprising at least one polysaccharide, a cross-linking agent and a porogen agent,

ii) transforming the solution into a hydrogel by placing said solution at a temperature from 4° C. to 80° C. for a sufficient time to allow cross-linking of said at least one polysaccharide,

iii) submerging said hydrogel into a solvent, and

iv) washing the porous polysaccharide scaffold obtained at step iii),

wherein the alkaline aqueous solution of step i) further comprises hydroxyapatite and wherein the porous polysaccharide scaffold lacks exogenously added cells and growth factors.

2. The porous polysaccharide scaffold according to claim 1 , wherein the porogen agent is selected from the group consisting of sodium chloride, calcium chloride, ammonium carbonate, ammonium bicarbonate, calcium carbonate, sodium carbonate, sodium bicarbonate and mixtures thereof.

3. The porous polysaccharide scaffold according to claim 1 , wherein a weight ratio of the at least one polysaccharide to the porogen agent is in a range from 1:50 to 50:1.

4. The porous polysaccharide scaffold according to claim 1 , wherein said at least one polysaccharide is selected from the group consisting of dextran, pullulan, agar, alginic acid, starch, hyaluronic acid, inulin, heparin, fucoidan, chitosan and mixtures thereof.

5. The porous polysaccharide scaffold according to claim 1 , wherein said at least one polysaccharide is a mixture of pullulan/dextran in a ratio in a range from 95:5 to 5:95.

6. The porous polysaccharide scaffold according to claim 1 , wherein said at least one polysaccharide is a mixture of pullulan/dextran/fucoidan in a ratio in a range from 70:20:10 to 50:20:30.

7. The porous polysaccharide scaffold according to claim 1 , wherein said cross-linking agent is selected from the group consisting of trisodium trimetaphosphate (STMP), phosphorus oxychloride (POCl 3 ), epichlorohydrin, formaldehydes, carbodiimides, glutaraldehydes, and mixtures thereof.

8. The porous polysaccharide scaffold according to claim 1 , wherein said hydroxyapatite is nano-hydroxyapatite.

9. The porous polysaccharide scaffold according to claim 8 wherein said nano-hydroxyapatite is obtained from a solution of phosphoric acid at a concentration between 0.3 to 1M, with a solution of calcium hydroxide at a concentration between 0.5 to 1.5M, through chemical precipitation at room temperature.

10. The porous polysaccharide scaffold according to claim 9 , wherein said phosphoric acid concentration is 0.6M and said calcium hydroxide concentration is 1M.

11. The porous polysaccharide scaffold of claim 10 , wherein said nano-hydroxide concentration is between 0.1 and 0.5% (w/v) or between 0.1 and 0.3% (w/v).

12. The porous polysaccharide scaffold according to claim 8 wherein a concentration of nano-hydroxyapatite in the alkaline aqueous solution is between 0.01 and 10% (w/v).

13. The porous polysaccharide scaffold according to claim 1 , wherein said porous polysaccharide scaffold contains pores from 1 μm to 500 μm in size and the porosity is from 4% to 75%.

14. The porous polysaccharide scaffold of claim 13 , wherein the pores are from 10 to 200 μm in size and the porosity is from 4% to 50%.

15. The porous polysaccharide scaffold according to claim 1 wherein said solvent is an aqueous solution.

16. The porous polysaccharide scaffold according to claim 1 , wherein a weight ratio of the at least one polysaccharide to said porogen agent is in a range from 1:30 to 30:1 (w/w).

17. The porous polysaccharide scaffold according to claim 16 , wherein said weight ratio is 75:25 (w/w).

18. The porous polysaccharide scaffold according to claim 16 , wherein said ratio is selected from the group consisting of 70:20:10 (w/w), 50:30:20 (w/w), and 73:22:5 (w/w).

Assignments (3)
CHANGE OF NAME Recorded Mar 25, 2022
From: UNIVERSITÉ DE PARIS
To: UNIVERSITÉ PARIS CITÉ
Reel/Frame 059504/0225 →
MERGER Recorded Jul 12, 2021
From: UNIVERSITE PARIS DIDEROT - PARIS 7
To: UNIVERSITE DE PARIS
Reel/Frame 056817/0647 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 26, 2017
From: AMEDEE, JOELLE; LETOURNEUR, DIDIER; LE VISAGE, CATHERINE; DERKAOUI, SIDI MOHAMMED; FRICAIN, JEAN-CHRISTOPHE; CATROS, SYLVAIN
To: INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE); UNIVERSITE DE BORDEAUX II VICTOR SEGALEN; UNIVERSITE PARIS DIDEROT - PARIS 7
Reel/Frame 043096/0974 →
Priority Claims (1)
EP 10305932 · Aug 31, 2010 · regional
Continuity (3)
Division 14728412 · Jun 2, 2015
Division 13819546
Related Publication 20170319741A1 · Nov 9, 2017